Helicobacter pylori Infection in Iran: Epidemiology, Treatment and Diagnosis
- Authors: Amin Talebi Bezmin Abadi, Johannes G. Kusters2
-
View Affiliations Hide Affiliations2 Department of Medical Microbiology, University Medical Center Utrecht, Netherlands
- Source: Helicobacter Pylori: A Worldwide Perspective 2014 , pp 216-233
- Publication Date: March 2014
- Language: English
Helicobacter pylori Infection in Iran: Epidemiology, Treatment and Diagnosis, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781608057375/chapter-10-1.gif
Helicobacter pylori infection contributes to the development of various gastroduodenal disorders. Clinical manifestation after H. pylori infection is an important issue for gastroenterologist. Design and optimizing usage of new drugs against H. pylori has always been a major topic in Helicobacter pylori (H. pylori) research. There are many articles published over the last decade on H. pylori treatment and diagnosis. Since the incidence, virulence, and resistance of H. pylori are different for each region diagnosis and treatment require a local approach. Iran is a country with a high rate of H. pylori infection and consequently a huge number of patients suffer from H. pylori induced digestive diseases. In this chapter we will present a comprehensive summary on H. pylori epidemiology, diagnosis and treatment in Iran over the last years.
-
From This Site
/content/books/9781608057375.chapter-10dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
